|
Pharma News: Dendreon, Optimer
|
Pharma News: Dendreon, Optimer
Dendreon (DNDN) said late yesterday that it has completed submission of the post-approval supplement for its Provenge application to the Food and Drug Administration. The FDA approved Provenge in April 2010, and the drug is in a new therapeutic class called autologous cellular immunotherapies designed to stimulate immune responses to certain tumors.
Video Length: 0
Date Found: November 11, 2010
Date Produced: November 11, 2010
View Count: 0
|
|
|
|
|
I got punched by an old guy, for farting near his wife. Read MoreComic book creator Stan Lee talks the future of the medium in the digital age. Panelists Zachary... Read MoreThe U.S. launch of Spotify is still on music lovers' minds. Join Zachary Levi, from NBC’s... Read MoreTuesday: Rupert Murdoch testifies before Parliament on the hacking scandal that brought down "News... Read MoreAfter a long slump, the home construction industry may be showing signs of life. But as Bill... Read More | 1 2 3 4 5 |
|
|
|